NCT03472456View on ClinicalTrials.gov

Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol?

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 22, 2018

Primary Completion Date

March 22, 2018

Study Completion Date

October 24, 2019

Conditions
PulpitidesEndodontic InflammationToothachesOperative Dentistry
Interventions
DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

Implementation of a pulp medication in compliance with the dental emergency management protocol: articaïne

DRUG

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Implementation of a pulp medication in compliance with the dental emergency management protocol: eugenol

Trial Locations (1)

67091

Les Hôpitaux Universitaires de Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT03472456 - Endodontic Medications for Irreversible Pulpitis: Articaine or Eugenol? | Biotech Hunter | Biotech Hunter